Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bertazzoli

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Research Communications in Chemical Pathology and Pharmacology|December 1, 1976
Effect of adriamycin on the activity of the succinate dehydrogenase-coenzyme Q10 reductase of the rabbit myocardiumC Bertazzoli, L Sala, L Ballerini, et al.
Tumori|March 1, 1972
[Ultrastructural changes of the nucleolus induced by adriamycin]G Lambertenghi Deliliers, T Ranzi, G Jean, et al.
Toxicology and Applied Pharmacology|November 1, 1972
Experimental toxicology of caeruleinT Chieli, C Bertazzoli, G Ferni, et al.
Giornale Italiano Di Chemioterapia|January 1, 1975
[Experimental cardiotoxicity of adriamycin]C Bertazzoli, E Solcia, L Sala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1997
Mapping of HLA class I binding motifs in forty-four fusion proteins involved in human cancersC Gambacorti-Passerini, C Bertazzoli, S Dermime, et al.
Tumori|January 16, 1998
HLA binding characteristics and generation of cytotoxic lymphocytes against peptides derived from oncogenic proteinsC Bertazzoli, E Marchesi, S Dermime, et al.
Toxicology and Applied Pharmacology|July 1, 1985
Experimental systemic toxicology of 4'-epidoxorubicin, a new, less cardiotoxic anthracycline antitumor agentC Bertazzoli, C Rovero, L Ballerini, et al.
Blood|August 15, 1996
In vitro transcription and translation inhibition by anti-promyelocytic leukemia (PML)/retinoic acid receptor alpha and anti-PML peptide nucleic acidC Gambacorti-Passerini, L Mologni, C Bertazzoli, et al.
Tumori|October 31, 1981
Cardiomyopathy of doxorubicin in experimental animals, Factors affecting the severity, distribution and evolution of myocardial lesionsE Solcia, L Ballerini, O Bellini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1996
Lack of T-cell-mediated recognition of the fusion region of the pml/RAR-alpha hybrid protein by lymphocytes of acute promyelocytic leukemia patientsS Dermime, C Bertazzoli, E Marchesi, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Research Communications in Chemical Pathology and Pharmacology|December 1, 1976
Effect of adriamycin on the activity of the succinate dehydrogenase-coenzyme Q10 reductase of the rabbit myocardiumC Bertazzoli, L Sala, L Ballerini, et al.
Tumori|March 1, 1972
[Ultrastructural changes of the nucleolus induced by adriamycin]G Lambertenghi Deliliers, T Ranzi, G Jean, et al.
Toxicology and Applied Pharmacology|November 1, 1972
Experimental toxicology of caeruleinT Chieli, C Bertazzoli, G Ferni, et al.
Giornale Italiano Di Chemioterapia|January 1, 1975
[Experimental cardiotoxicity of adriamycin]C Bertazzoli, E Solcia, L Sala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1997
Mapping of HLA class I binding motifs in forty-four fusion proteins involved in human cancersC Gambacorti-Passerini, C Bertazzoli, S Dermime, et al.
Tumori|January 16, 1998
HLA binding characteristics and generation of cytotoxic lymphocytes against peptides derived from oncogenic proteinsC Bertazzoli, E Marchesi, S Dermime, et al.
Toxicology and Applied Pharmacology|July 1, 1985
Experimental systemic toxicology of 4'-epidoxorubicin, a new, less cardiotoxic anthracycline antitumor agentC Bertazzoli, C Rovero, L Ballerini, et al.
Blood|August 15, 1996
In vitro transcription and translation inhibition by anti-promyelocytic leukemia (PML)/retinoic acid receptor alpha and anti-PML peptide nucleic acidC Gambacorti-Passerini, L Mologni, C Bertazzoli, et al.
Tumori|October 31, 1981
Cardiomyopathy of doxorubicin in experimental animals, Factors affecting the severity, distribution and evolution of myocardial lesionsE Solcia, L Ballerini, O Bellini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1996
Lack of T-cell-mediated recognition of the fusion region of the pml/RAR-alpha hybrid protein by lymphocytes of acute promyelocytic leukemia patientsS Dermime, C Bertazzoli, E Marchesi, et al.
Pageof 3